Evaluation of Calcified Coronary Lesion Preparation With the Naviscore Scoring Balloon

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Mons

About this trial

The purpose of this clinical study is to evaluate the effectiveness and safety of a specialized medical device, the Naviscore scoring balloon, in preparing calcified coronary artery narrowings before the implantation of a drug-eluting stent. During percutaneous coronary interventions, the presence of calcified plaques in the heart arteries represents a major challenge because it can prevent stents from expanding fully. When a stent remains under-expanded, it significantly increases the long-term risk of arterial re-narrowing or blood clot formation. To optimize stent expansion, appropriate preparation of the diseased vessel section before stent insertion is a critical phase.

This study is a prospective, multi-center randomized trial designed to test the hypothesis that treating calcified coronary lesions with the Naviscore scoring balloon will achieve a better stent expansion and a larger final minimal stent area compared to standard lesion preparation using regular non-compliant balloons. Eligible participants will be randomized in a one-to-one ratio to one of these two lesion preparation strategies. For all included patients, standard drug-eluting stents will be deployed. The study will use intravascular ultrasound imaging to evaluate the final minimum area of the stent directly inside the treated artery at the site of the highest initial calcium burden. Participant health and clinical outcomes will be monitored for up to twelve months following the procedure.

Eligibility criteria

Qualifiers

Patient written consent is given, ≥18 years.

A de novo lesion to be treated in a vessel between 2.5 and 4.0 mm.

Moderate to heavily calcified lesions detected by coronary angiography on two orthogonal views, and confirmed by IVUS if the lesion can be crossed with the catheter.

Disqualifiers

Patient <18 years old.

Pregnant female.

Contraindication to dual antiplatelet therapy.

Thrombocytopenia (under 100 000).

Trial design

Treatments tested in this trial

  • Scoring Balloon PTCA Catheter
  • Non-Compliant (NC) Angioplasty Balloon

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Mons

Lead sponsor

iVascular S.L.U.

Collaborator